Fangzhou Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Fangmin Xie
Chief executive officer
CN¥6.7m
Total compensation
| CEO salary percentage | 83.2% |
| CEO tenure | 5.2yrs |
| CEO ownership | 20.6% |
| Management average tenure | no data |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥862m |
| Mar 31 2024 | n/a | n/a | -CN¥529m |
| Dec 31 2023 | CN¥7m | CN¥6m | -CN¥197m |
| Dec 31 2022 | CN¥5m | CN¥5m | -CN¥383m |
| Dec 31 2021 | CN¥3m | CN¥2m | -CN¥304m |
Compensation vs Market: Fangmin's total compensation ($USD923.70K) is above average for companies of similar size in the Hong Kong market ($USD480.33K).
Compensation vs Earnings: Fangmin's compensation has increased whilst the company is unprofitable.
CEO
Fangmin Xie (45 yo)
5.2yrs
Tenure
CN¥6,695,000
Compensation
Mr. Fangmin Xie serves as Chief Executive Officer of Guangdong Jianke Pharmaceutical Co., Ltd. Mr. Xie is Founder, Chairman of the Board and Chief Executive Officer of Fangzhou Inc. and serves as Director...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 5.2yrs | CN¥6.70m | 20.64% HK$ 1.6b | |
| Executive Director | 3.3yrs | CN¥1.84m | 1.75% HK$ 133.2m | |
| Chief Strategy Officer & Executive Director | 5.2yrs | CN¥4.15m | 21.42% HK$ 1.6b | |
| Non-executive Director | 3.9yrs | no data | no data | |
| Independent non-executive Director | less than a year | no data | no data | |
| Independent non-executive Director | less than a year | no data | no data | |
| Independent Non-executive Director | less than a year | no data | no data |
3.3yrs
Average Tenure
50yo
Average Age
Experienced Board: 6086's board of directors are considered experienced (3.3 years average tenure).